Antibody-guided in vivo imaging of Aspergillus fumigatus lung infections during antifungal azole treatment
Invasive pulmonary aspergillosis is a life-threatening fungal lung disease devoid of specific rapid diagnosis and with limited therapeutic options. Here, the authors show how state-of-the-art imaging approaches can enable specific diagnosis and therapy monitoring of this infection.
Guardado en:
Autores principales: | Sophie Henneberg, Anja Hasenberg, Andreas Maurer, Franziska Neumann, Lea Bornemann, Irene Gonzalez-Menendez, Andreas Kraus, Mike Hasenberg, Christopher R. Thornton, Bernd J. Pichler, Matthias Gunzer, Nicolas Beziere |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c368bc0bd6144b6f8b5657fa52156a38 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Development of azole resistance in Aspergillus fumigatus during azole therapy associated with change in virulence.
por: Maiken Cavling Arendrup, et al.
Publicado: (2010) -
Azole-induced cell wall carbohydrate patches kill Aspergillus fumigatus
por: Bernadette Geißel, et al.
Publicado: (2018) -
Identification of a putative Crf splice variant and generation of recombinant antibodies for the specific detection of Aspergillus fumigatus.
por: Mark Schütte, et al.
Publicado: (2009) -
The response regulator Skn7 of Aspergillus fumigatus is essential for the antifungal effect of fludioxonil
por: Sebastian Schruefer, et al.
Publicado: (2021) -
Discovery of a HapE mutation that causes azole resistance in Aspergillus fumigatus through whole genome sequencing and sexual crossing.
por: Simone M T Camps, et al.
Publicado: (2012)